These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36552624)

  • 1. Evaluation of Selected Oxidant/Antioxidant Parameters in Patients with Relapsing-Remitting Multiple Sclerosis Undergoing Disease-Modifying Therapies.
    Bizoń A; Chojdak-Łukasiewicz J; Kołtuniuk A; Budrewicz S; Pokryszko-Dragan A; Piwowar A
    Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
    Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
    Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
    Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
    Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Relationship between Antioxidant Enzymes, Oxidative Stress Markers, and Clinical Profile in Relapsing-Remitting Multiple Sclerosis.
    Bizoń A; Chojdak-Łukasiewicz J; Budrewicz S; Pokryszko-Dragan A; Piwowar A
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
    Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
    J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.
    Güntaş G; Engin B; Ekmekçi ÖB; Kutlubay Z; Ekmekci H; Songür A; Uzunçakmak TK; Vehid HE; Serdaroğlu S; Tüzün Y; Uzun H
    Ann Dermatol; 2015 Apr; 27(2):178-83. PubMed ID: 25834357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis.
    Obradovic D; Andjelic T; Ninkovic M; Dejanovic B; Kotur-Stevuljevic J
    Neurol Sci; 2021 Aug; 42(8):3241-3247. PubMed ID: 33241537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
    Najafizadeh SR; Amiri K; Moghaddassi M; Khanmohammadi S; Mirmiranpour H; Nakhjavani M
    Clin Rheumatol; 2021 Oct; 40(10):4019-4026. PubMed ID: 34050440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
    Juybari KB; Ebrahimi G; Momeni Moghaddam MA; Asadikaram G; Torkzadeh-Mahani M; Akbari M; Mirzamohammadi S; Karimi A; Nematollahi MH
    Mult Scler Relat Disord; 2018 Jan; 19():79-84. PubMed ID: 29156301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between ischemia modified albumin and oxidative stress parameters in patients with cardiac syndrome X.
    Demir B; Ozyazgan S; Korkmaz GG; Karakaya O; Aciksari G; Uygun T; Onal B; Uzun H
    Clin Lab; 2013; 59(11-12):1319-29. PubMed ID: 24409667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.
    Barut O; Vural P; Şirin Ş; Aydin S; Dizdar Y
    Acta Odontol Scand; 2012 Jul; 70(4):303-8. PubMed ID: 21815836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
    Seven A; Aslan M; Incir S; Altıntaş A
    Folia Neuropathol; 2013; 51(1):58-64. PubMed ID: 23553138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
    Rasoul AA; Khudhur ZO; Hamad MS; Ismaeal YS; Smail SW; Rasul MF; Mohammad KA; Bapir AA; Omar SA; Qadir MK; Rajab MF; Salihi A; Kaleem M; Rizwan MA; Qureshi AS; Iqbal ZM; Qudratullah
    Mult Scler Relat Disord; 2021 Nov; 56():103228. PubMed ID: 34492630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
    Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
    Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
    Sumowski JF; Leavitt VM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1298-302. PubMed ID: 24561056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes.
    Heidari F; Rabizadeh S; Rajab A; Heidari F; Mouodi M; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Life Sci; 2020 Nov; 260():118422. PubMed ID: 32946914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma thiol/disulphide homeostasis changes in patients with relapsing-remitting multiple sclerosis.
    Ozben S; Kucuksayan E; Koseoglu M; Erel O; Neselioglu S; Ozben T
    Int J Clin Pract; 2021 Jul; 75(7):e14241. PubMed ID: 33891773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.